Italia markets open in 15 minutes
Dow Jones
39.112,16 -299,05 (-0,76%) Nasdaq
17.717,65 +220,84 (+1,26%) Nikkei 225
39.667,07 +493,92 (+1,26%) EUR/USD
1,0701 -0,0015 (-0,14%) Bitcoin EUR
57.528,25 +393,40 (+0,69%) CMC Crypto 200
1.278,79 -4,99 (-0,39%)
Enveric Biosciences, Inc. (SLZA.F)
Frankfurt - Frankfurt Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
In data: 03:29PM CEST. Mercato aperto.
| Chiusura precedente | 0,5970 |
| Aperto | 0,6120 |
| Denaro | 0,5900 x N/D |
| Domanda | 0,6070 x N/D |
| Min-Max giorno | 0,5970 - 0,6130 |
| Intervallo di 52 settimane | 0,5610 - 3,0700 |
| Volume | |
| Media Volume | 28 |
| Capitalizzazione | 4,628M |
| Beta (mensile su 5 anni) | 0,51 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -5,9800 |
| Prossima data utili | 12 ago 2024 - 16 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Diamond Equity Research Initiates Coverage on Enveric Biosciences Inc. (NASDAQ: ENVB)
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Enveric Biosciences Inc. (NASDAQ: ENVB). The in-depth 23-page initiation report includes detailed information on the Enveric Bioscience’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Second Wave of Psychedelics, Reg
© 2024 Yahoo. Tutti i diritti riservati.